Stem Cell Therapies - Calgary November 25
Out of Stock

Price:

 Stem Cell Therapies
"From the Lab to the Bedside" 

Registration Open October 1
"Demystifying" innovations and advancing the commercialization of Alberta's emerging technologies
Calgary November 25  - Kerby Centre 7- 9:30pm
Co-Host: Bio Alberta and Alberta Council of Technologies
Co-organizers: the Alberta Council of Technologies and the LifeStar Institute Canada
Each of the two public  events are designed to engage Albertans in a patient-focused dialogue to demystify  stem cell therapies. The forums have been designed to resolve three objectives:
 
1) to increase public and patient awareness of stem cell therapies,  its implications on health care delivery and their potential in preventing and treating degenerative diseases,

2) to establish Alberta's bio-tech sector as a world leader in the development of stem cell technologies, and

3) to prepare Alberta for the early delivery of stem cell therapy.

BACKGROUND
Because of an aging population and a reduction in infant mortality (due to innovations in medicine and public health),  society is faced with an ever-increasing number of people suffering degenerative diseases such as Alzheimer's, Parkinson's, Huntington's, Arthritis, etc.
 
In fact, the treatment of degenerative diseases resulting from aging is currently consuming 80% of health care budgets of most developed nations.

But while the costs of treatment are increasing, they pale in  comparison with the costs associated with the  lost contributions and productivity of patients and their caregivers.
 
According to recent studies (Milken 2007), the combined cost of caregivers’ unpaid labour and the lost productivity of those suffering chronic degenerative conditions outweighed treatment
expenditures FOUR FOLD in the U.S. during 2003!
 
By focusing solely on treatment costs, strategies for short term cost cutting such as health care rationing have little effect. Why? Such strategies merely focus on "managing" degenerative disease rather than rehabilitation, which would reduce the devastating costs of lost productivity.
 
Fortunately, solutions are in sight.
 
Bio-technology, by creating therapies that employ stem cells found in one's own body, will be able to treat degenerative disease and restore damaged and aged tissues, cells and organs.
 
Caution is warranted, however. While stem cell therapies have the potential to transform health care and the features of aging, as we know them, overly optimistic promises – too much, too fast - may impede their adoption.
 
The two public forums being held in Calgary and Edmonton are designed to address the realities underlying these technologies, identify impediments to their commercialization and contribute to the health and the economy of Alberta.
 
              * * *
The Forums in Calgary and Edmonton will be broadcast live on the internet and are not to be missed!
On-line Event Admission Registration - Opens October 1, 2009

  • Free Admission
  • Refreshments
  • Free Parking
 
On-line Event  Broadcast
Registration
 
FREE On-line Internet Simultaneous Video-broadcast
_______________________
 
Additional Information
 
Please click here for:
   
PPT Presentation
PDF Presentation
Sponsor Flyers
Stem Cell Blog
___________________

SPONSORS

     







Keynote Presentation

   Presenter: Robert Burrell, PhD

Realizing the Promise of Stem Cell Therapies in Alberta

An introduction to stem cells and their potential for the treatment of degenerative disease highlighting the pathway and complexities of their development from discovery through to their application

Dr. Robert Burrell is the winner of the National Award of the Ernest C. Manning Awards Foundation. The Award recognizes Canadians who have demonstrated innovative talent in developing and successfully marketing a new concept, process or procedure.  Read more...

Dr. Burrell is the Canada Research Chair in Nanostructured Biomaterials and Chairman of the Department of Biomedical Engineering, Faculties of Engineering and Medicine & Dentistry, at the University of Alberta, with noteworthy achievements in the application of silver and nanostructures in tissue regeneration. Recent interests include the formation of BERRI as an Alberta-based, multidisciplinary academic network for advancing biomedical innovations, including stem cell therapeutics, from the laboratory to the bedside.
Event Program

  7:10     Introductions and Objectives
  7:15  Keynote Presentation - Dr. Robert Burrell
 7:45  Moderated Response Panels
  - Patient representatives
  - Specialized expertise

 8:15    Audience O&A
 8:55  Synthesis - "Where from here?"
  9:00     Refreshments - Mix and Mingle!
  9:30           Goodnight

Simultaneous live Internet Broadcast of the Calgary and Edmonton events.
Event Information

With these two events,
ABCtech and 
LifeStar Institute Canada are building on the success of two previous open public forums that were held in Edmonton and Calgary in June 2009, during which keynote presentations on the promise of stem cell therapies were discussed. The audiences and expert response panels consisted of health care, government, research, industry and finance interests.  
 
The success of both previous forums led to the conclusion that further meetings – focusing on patients, caregivers and the general public - were warranted.
 
The result is two back-to-back public forums in Calgary and Edmonton planned for November, 2009. The forums aim is to demystify stem cell therapies and discuss their implications on the future of health care and aging. 

Planning sessions, which took place in Edmonton on Aug 4 and Calgary on August 25 between patient groups, researchers, industry representatives and commercial organizations, identified the need to clarify and communicate the following messages:

1) There are ethical methods of producing stem cells that do not involve embryos; stem cells have been found throughout the adult body.

2) The process of bringing stem cell therapy from the lab to the bedside is complex; the hurdles should be highlighted.

3) A realistic time frame for treatment delivery needs to be understood by those who are most anxious to see progress.

4) Emphasize that financing, while important to advance research, will not alone increase the speed of stem cell therapy to the bedside.


5) Patients, caregivers, and the public should be engaged in pulling research to market.
 
6) It is important that the public understand the ramifications of such a radically different therapy on aging, lifestyles and health care delivery.

PUBLIC FORUM DESIGN
The 2-hour evening program will be broadcast over Internet and feature:
  • A Presentation by Dr. Robert Burrell, a recognized expert in regenerative technologies and their commercialization
  • A Moderated dialogue between two Response Panels: One composed of representatives of today's patients,  caregivers and service practitioners. The 2nd composed of experts in health economics, ethics and theology, business development, biotech research and lifestyle change.
  • Open discussion with the audience posing questions to both Response Panels and the Presenter.
  •  A wrap-up summary of the Proceedings and "What comes next?"

Refreshments will follow with an opportunity to "mix and mingle" with the Presenter, Moderator  and Panellists.


Based on the two Forum's proceedings, the merit of conducting a  national/international stem cell therapeutics Conference in the fall of 2010 will be considered.
 
                    ***
 
We believe that it is essential - and democratic - for the public to be engaged in  advance discussion on the implications of emerging technologies. Such a dialogue is particularly relevant in the case of stem cell therapeutics, which offer such extraordinary promise and potential to transform health-care delivery and aging itself.
 
Our hope is that by engaging the public in an advanced discussion on emerging technologies we will encourage public and private support and collaboration for speeding up the safe development of these technologies for Albertans, the economy and future
generations.